Amelia M. Huehls

934 total citations
15 papers, 704 citations indexed

About

Amelia M. Huehls is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Amelia M. Huehls has authored 15 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Amelia M. Huehls's work include DNA Repair Mechanisms (10 papers), PARP inhibition in cancer therapy (7 papers) and CAR-T cell therapy research (2 papers). Amelia M. Huehls is often cited by papers focused on DNA Repair Mechanisms (10 papers), PARP inhibition in cancer therapy (7 papers) and CAR-T cell therapy research (2 papers). Amelia M. Huehls collaborates with scholars based in United States. Amelia M. Huehls's co-authors include Tiffany A. Coupet, Charles L. Sentman, Larry M. Karnitz, Catherine J. Huntoon, Scott H. Kaufmann, Jill M. Wagner, Andrea E. Wahner Hendrickson, Karen S. Flatten, Shari L. Sutor and Liyi Geng and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Amelia M. Huehls

13 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amelia M. Huehls United States	10	488	395	166	144	55	15	704
Heather Kostner United States	7	413 0.8×	263 0.7×	102 0.6×	208 1.4×	107 1.9×	12	624
David J. Zahavi United States	12	340 0.7×	306 0.8×	308 1.9×	197 1.4×	20 0.4×	13	803
Francesca Zammarchi United Kingdom	13	534 1.1×	344 0.9×	161 1.0×	192 1.3×	41 0.7×	47	875
Casey W. Shuptrine United States	10	264 0.5×	225 0.6×	294 1.8×	179 1.2×	17 0.3×	13	588
Andrea Stern Ferris United States	3	580 1.2×	570 1.4×	642 3.9×	150 1.0×	40 0.7×	6	1.1k
Kimberly H. Harrington United States	11	492 1.0×	343 0.9×	206 1.2×	254 1.8×	307 5.6×	17	807
Slava Stamova Germany	13	617 1.3×	163 0.4×	388 2.3×	177 1.2×	36 0.7×	22	752
Andrew Scott United States	10	748 1.5×	339 0.9×	707 4.3×	176 1.2×	42 0.8×	19	1.1k
Sarah C. Garrett-Thomson United States	8	497 1.0×	188 0.5×	387 2.3×	66 0.5×	25 0.5×	10	714
Bart E.C.G. de Goeij Netherlands	8	408 0.8×	322 0.8×	189 1.1×	468 3.3×	70 1.3×	10	788

Countries citing papers authored by Amelia M. Huehls

Since Specialization

Citations

This map shows the geographic impact of Amelia M. Huehls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia M. Huehls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia M. Huehls more than expected).

Fields of papers citing papers by Amelia M. Huehls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia M. Huehls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia M. Huehls. The network helps show where Amelia M. Huehls may publish in the future.

Co-authorship network of co-authors of Amelia M. Huehls

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia M. Huehls. A scholar is included among the top collaborators of Amelia M. Huehls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia M. Huehls. Amelia M. Huehls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Huehls, Amelia M., et al.. (2026). Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer. Science Translational Medicine. 18(832). eadt8706–eadt8706.

Huehls, Amelia M., Enis Kostallari, Sheng Cao, et al.. (2025). Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease. Journal of Medicinal Chemistry. 68(8). 8091–8105. 1 indexed citations

Hou, Xiaonan, Amelia M. Huehls, Xinyan Wu, et al.. (2024). Abstract 4538: Brigatinib induces synergy with PARP inhibitors through dual inhibition of FAK and EphA2 in high-grade serous ovarian carcinoma. Cancer Research. 84(6_Supplement). 4538–4538.

Huehls, Amelia M., et al.. (2022). Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress. Journal of Biological Chemistry. 298(4). 101777–101777. 2 indexed citations

Huehls, Amelia M., et al.. (2021). VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases. Molecular Cancer Therapeutics. 20(9). 1561–1571. 9 indexed citations

Kanakkanthara, Arun, Xiaonan Hou, Valentina Zanfagnin, et al.. (2021). Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma. Cancer Research. 82(2). 307–319. 14 indexed citations

Vincelette, Nicole D., Husheng Ding, Amelia M. Huehls, et al.. (2019). Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo. Scientific Reports. 9(1). 3617–3617. 10 indexed citations

Coupet, Tiffany A., Amelia M. Huehls, Tong Zhang, et al.. (2017). NKG2D Ligand–Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors. Molecular Cancer Therapeutics. 16(7). 1335–1346. 15 indexed citations

Huehls, Amelia M., Catherine J. Huntoon, Poorval Joshi, et al.. (2015). Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination. Molecular Pharmacology. 89(1). 53–62. 42 indexed citations

10.

Huehls, Amelia M., Tiffany A. Coupet, & Charles L. Sentman. (2014). Bispecific T‐cell engagers for cancer immunotherapy. Immunology and Cell Biology. 93(3). 290–296. 336 indexed citations

11.

Huntoon, Catherine J., Karen S. Flatten, Andrea E. Wahner Hendrickson, et al.. (2013). ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status. Cancer Research. 73(12). 3683–3691. 158 indexed citations

12.

Huehls, Amelia M., Jill M. Wagner, Catherine J. Huntoon, & Larry M. Karnitz. (2012). Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination. Molecular Pharmacology. 82(4). 767–776. 31 indexed citations

13.

Huehls, Amelia M., Jill M. Wagner, Catherine J. Huntoon, et al.. (2011). Poly(ADP-Ribose) Polymerase Inhibition Synergizes with 5-Fluorodeoxyuridine but not 5-Fluorouracil in Ovarian Cancer Cells. Cancer Research. 71(14). 4944–4954. 42 indexed citations

14.

Geng, Liyi, Amelia M. Huehls, Jill M. Wagner, Catherine J. Huntoon, & Larry M. Karnitz. (2011). Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil. PLoS ONE. 6(12). e28862–e28862. 34 indexed citations

15.

Noblitt, Scott D., et al.. (2006). The role of metal ion binding in generating 8-hydroxy-2′-deoxyguanosine from the nucleoside 2′-deoxyguanosine and the nucleotide 2′-deoxyguanosine-5′-monophosphate. Journal of Inorganic Biochemistry. 101(3). 536–542. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact